The pharma major beat analysts' expectations in the fourth quarter of 2024, despite looming competition for its top heart drug Entresto. The watchdog blocked access to DeepSeek after the companies ...
It announced that it recently completed a major test involving over 3,300 kilometers across multiple climates for its ...